Applications: |
Immunodepletion/Immunocompetition |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
cIAP2 Blocking Peptide for STJ500539 is synthetically produced from the 545-620 sequence and is suitable for use in western blot applications. |
Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Immunogen Region: |
545-620 |
Specificity: |
This blocking peptide is recommended for use in combination with cIAP2 antibody, STJ500539 |
Immunogen: |
Synthetic peptide taken within amino acid region 545-620 on human cIAP2 protein. |
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance